None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy male and female adults aged 19 to 65 years 2. Individuals who can undergo patch application on the upper back and allow clear evaluation 3. No acute or chronic dermatologic diseases or conditions that may interfere with irritation assessment 4. Provided written informed consent after being fully informed of the study purpose and procedures 5. No use of topical steroids, retinoids, AHA/BHA, or other skin-irritating products within the past two weeks
Exclusion criteria
Exclusion criteria: 1. Individuals with wounds, infections, active skin lesions, or severe dryness/sensitivity at the test site 2. History of chronic dermatologic diseases such as atopic dermatitis, contact dermatitis, or psoriasis 3. Use of medications or treatments that may affect skin reactivity during the study period 4. Pregnant or breastfeeding women 5. Known hypersensitivity or allergy to the test product or patch materials 6. Individuals deemed unsuitable for participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of skin irritation reactions (erythema, edema, etc.) based on ICDRG criteria after 24-hour patch application | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-reported subjective symptoms such as itching, stinging, or discomfort | — |
Countries
Korea, Republic of
Contacts
SKINMED